A dual-targeting hybrid platinum(IV) prodrug for enhancing efficacy

	A dual-targeting hybrid platinum(IV) prodrug for enhancing efficacy
	Xiao HH ; Yan LS ; Zhang Y ; Qi RG ; Li WL ; Wang R ; Liu S ; Huang YB ; Li YX ; Jing XB
刊名	chemical communications
	2012
卷号	48 期号:87 页码:10730-10732
关键词	CISPLATIN CANCER DICHLOROACETATE COMPLEXES MITOCHONDRIA THERAPY DRUG
ISSN号	1359-7345
通讯作者	li yx
中文摘要	a multifunctional hybrid platinum(iv) prodrug, which consists of both the mitochondria-targeting drug dca and the dna-crosslinking drug cisplatin, was synthesized and tethered to a carrier polymer to further self-assemble into micelles for intracellular delivery.
收录类别	SCI收录期刊论文
语种	英语
WOS记录号	WOS:000309544100008
公开日期	2013-06-09
内容类型	期刊论文
源URL	[http://ir.ciac.jl.cn/handle/322003/48445]
专题	长春应用化学研究所_长春应用化学研究所知识产出_期刊论文
推荐引用方式 GB/T 7714	Xiao HH,Yan LS,Zhang Y,et al. A dual-targeting hybrid platinum(IV) prodrug for enhancing efficacy[J]. chemical communications,2012,48(87):10730-10732.
APA	Xiao HH.,Yan LS.,Zhang Y.,Qi RG.,Li WL.,...&Jing XB.(2012).A dual-targeting hybrid platinum(IV) prodrug for enhancing efficacy.chemical communications,48(87),10730-10732.
MLA	Xiao HH,et al."A dual-targeting hybrid platinum(IV) prodrug for enhancing efficacy".chemical communications 48.87(2012):10730-10732.